Rhenman & Partners Asset Management AB »

Mineralys Therapeutics shares owned by Rhenman & Partners Asset Management AB

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Rhenman & Partners Asset Management AB from 13F filings

Historical chart of Rhenman & Partners Asset Management AB investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Rhenman & Partners Asset Management AB

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.3M 165k 37.92